Literature DB >> 7689980

Mechanisms of the inhibition of reverse transcription by unmodified and modified antisense oligonucleotides.

T Hatta1, S G Kim, H Nakashima, N Yamamoto, K Sakamoto, S Yokoyama, H Takaku.   

Abstract

We demonstrated that unmodified and modified (phosphorothioate) oligonucleotides prevent cDNA synthesis by AMV or HIV reverse transcriptases. Antisense oligonucleotide/RNA hybrids specifically arrest primer extension. The blockage involves the degradation of the RNA fragment bound to the antisense oligonucleotide by the reverse transcriptase-associated RNase H activity. However, the phosphorothioate oligomer inhibited polymerization by binding to the AMV RT rather than to the template RNA, whereas there was no competitive binding of the phosphorothioate oligomer on the HIV RT during reverse transcription.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7689980     DOI: 10.1016/0014-5793(93)80264-u

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  7 in total

1.  Efficient in vitro inhibition of HIV-1 gag reverse transcription by peptide nucleic acid (PNA) at minimal ratios of PNA/RNA.

Authors:  U Koppelhus; V Zachar; P E Nielsen; X Liu; J Eugen-Olsen; P Ebbesen
Journal:  Nucleic Acids Res       Date:  1997-06-01       Impact factor: 16.971

2.  Gene-targeted inhibition of transactivation of human immunodeficiency virus type-1 (HIV-1)-LTR by antisense oligonucleotides.

Authors:  I Demirhan; O Hasselmayer; D Hofmann; A Chandra; F P Svinarchuk; V V Vlassov; J Engels; P Chandra
Journal:  Virus Genes       Date:  1995-01       Impact factor: 2.332

3.  Analysis of oligo(deoxynucleoside phosphorothioate)s and their diastereomeric composition.

Authors:  A Wilk; W J Stec
Journal:  Nucleic Acids Res       Date:  1995-02-11       Impact factor: 16.971

4.  Anti-human immunodeficiency virus type 1 activity of phosphorothioate analogs of oligodeoxynucleotides: penetration and localization of oligodeoxynucleotides in HIV-1-infected MOLT-4 cells.

Authors:  H Nakashima; Y Shoji; S G Kim; J Shimada; Y Mizushima; M Ito; N Yamamoto; H Takaku
Journal:  Nucleic Acids Res       Date:  1994-11-25       Impact factor: 16.971

Review 5.  Antisense inhibition of virus infections.

Authors:  R E Kilkuskie; A K Field
Journal:  Adv Pharmacol       Date:  1997

6.  Targeting a pre-mRNA structure with bipartite antisense molecules modulates tau alternative splicing.

Authors:  Eleanor Peacey; Lilia Rodriguez; Yang Liu; Michael S Wolfe
Journal:  Nucleic Acids Res       Date:  2012-07-25       Impact factor: 16.971

7.  Antiviral effect of phosphorothioate oligodeoxyribonucleotides complementary to human immunodeficiency virus.

Authors:  S G Kim; T Hatta; S Tsukahara; H Nakashima; N Yamamoto; Y Shoji; K Takai; H Takaku
Journal:  Bioorg Med Chem       Date:  1995-01       Impact factor: 3.461

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.